New Data out from Regenexx this week shows that BMI may not impact outcomes of stem cell procedures. The data is based on the Regenexx advanced treatment registry, which collects outcome information as patients are treated. Their biostatistician queried the database for Regenexx-SD (same-day) knee stem cell treatment patients vs. their Body Mass Index (BMI). BMI means the patient’s weight vs. their height. The current guidelines state that normal weight is a BMI of 18.5-25 and overweight is 25-30 and obese is >30.
BMI had previously been considered to be one factor that may produce different outcomes for an individual, but the new data shows that at 1 month, 3 month, 6 months and 12 month follow-ups after the procedure, there was no indication that a high BMI had any impact on a patient’s outcome.
Comments are closed.